B3GNT5


HTML Blog Post: b3gnt5

Description:

b3gnt5 is a gene that encodes a glycosyltransferase enzyme. This enzyme is responsible for adding a specific type of sugar molecule (N-acetylglucosamine) to proteins. b3gnt5 is expressed in a variety of tissues, including the brain, heart, and kidneys.

Associated Diseases:

Mutations in the b3gnt5 gene have been linked to several genetic disorders, including:

  • Congenital disorders of glycosylation type IIi (CDG-IIi): CDG-IIi is a rare metabolic disorder that affects the glycosylation of proteins. Symptoms of CDG-IIi can include intellectual disability, seizures, and developmental delay.
  • Infantile-onset spinocerebellar ataxia (IOSCA): IOSCA is a rare neurodegenerative disorder that affects the cerebellum. Symptoms of IOSCA can include difficulty walking, speech problems, and eye movement abnormalities.
  • Microcephaly and seizures: Some mutations in the b3gnt5 gene have been associated with microcephaly (small head size) and seizures in children.

Did you Know ?

Mutations in the b3gnt5 gene are estimated to occur in approximately 1 in 100,000 individuals.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.